Press Resease

Topical Drug Delivery Market: By Product (Semi-Solid Formulations, Transdermal Products, Solid Formulations, and Liquid Formulations), By Route of Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Vaginal Drug Delivery, and Rectal Drug Delivery), By Facility of Use (Homecare Settings, Burn Centers, Hospitals & Clinics, and Other Facilities), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 06-Feb-2020 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4763 Status : Published

The global topical drug delivery market was estimated at 94.6 (USD Billion) in 2019 and is projected to be valued at 125 (USD Billion) by 2025 at a CAGR of 5.7%.

Description

The global topical drug delivery market was estimated at 94.6 (USD Billion) in 2019 and is projected to be valued at 125 (USD Billion) by 2025 at a CAGR of 5.7%. The report offers valuation and analysis of Topical Drug Delivery Market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Billion).

Key Growth Drivers

Rise in the incidences of burn injuries, growing frequency of eye & skin disorders, and surge in the number of diabetics will embellish the market growth over the forecast period. Furthermore, huge occurrence of skin ailments and burn injuries along with need for deep penetration of medicines in the body will enlarge the scope of the market over the forthcoming years. Moreover, topical drug delivery across the skin provides numerous benefits like sustained medicine release, reduction in oscillations in plasma medicine proportion, and circumvention of first-pass metabolism along with enhancing of patient compliance.

Furthermore, with growing need to enhance drug absorption through skin, new topical drug delivery systems are used along with the nanotechnology.  This will enable in overcoming the skin barrier. For instance, lipid-based nano-delivery systems will facilitate effective drug delivery through skin.

Our report also provides the current developments taking place in the industry along with the competitive moves & strategies adopted by the market players to expand their business. Let us discuss about some of the reputed brands in the topical drug delivery industry.

Global Topical Drug Delivery Market

MedPharm

In a key strategic move that can positively impact the topical drug delivery industry, MedPharm – a key manufacturer of drug delivery designs & systems – has developed in-vitro models that will assist the generic drug manufacturers to safely demonstrate the bioequivalence of generic medicines without conducting trials of the drugs on humans. Reportedly, the in-vitro models are predicted to minimize the costs & risks for these topically delivered generic drugs. Furthermore, the breakthrough is likely to help in reducing the entry barrier for the generic drug producers in topical drug delivery business.

Semi-Solid Formulations Segment To Dominate Product Landscape By 2025

The segmental growth over the forecast timeline is owing to high patient accessibility of topical gels along with rapid release of medicines. Moreover, the semi-solid formulations help in preventing skin irritation.

Homecare Settings To Contribute Majorly Towards the Market Share Over 2019-2025

The growth of the segment over the forecast timeline is attributed to a surge in the number of customers preferring the home-based therapies along with the end-user convenience and affordability due to taking treatment at homes.

North American Market To Accrue Highest Gains Over Forecast Timespan

The topical drug delivery industry in North America is set to record highest CAGR over the forecast timeline. The regional market growth is attributed to huge incidences of skin ailments, introduction & approval of new topical drug designs, and government aid.

Key players influencing the market growth and profiled in the report include

Nestle S.A., Johnson & Johnson, GlaxoSmithKline plc, Novartis AG, Merck & Co, Bausch Health Companies Inc., Hisamitsu Pharmaceutical Co., Inc., Bayer AG, Cipla Limited, Glenmark Pharmaceuticals, Mylan N.V., and Crescita Therapeutics Inc.

The global topical drug delivery market is segmented as follows:

By Product

  • Semi-solid Formulations
    • Creams
    • Ointments
    • Lotions
    • Gels
    • Pastes
  • Liquid Formulations
    • Suspensions
    • Solutions
  • Solid Formulations
    • Powders
    • Suppositories
  • Transdermal Products
    • Transdermal Patches
    • Transdermal Semi-solids

By Route of Administration

  • Dermal Drug Delivery
  • Ophthalmic Drug Delivery
  • Rectal Drug Delivery
  • Vaginal Drug Delivery
  • Nasal Drug Delivery

By Facility of use

  • Homecare Settings
  • Hospitals & Clinics
  • Burn Centers
  • Other Facilities (academic & research institutes and diagnostic centers)

By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Topical Drug Delivery Market, 2016-2025 (USD Billion)
    • 2.2. Topical Drug Delivery Market: Snapshot
  • Chapter 3. Global Topical Drug Delivery Market- Industry Analysis
    • 3.1. Topical Drug Delivery Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Rise in the cases of burn injuries & growing occurrence of skin ailments
      • 3.2.2. A prominent inflation witnessed in the number of diabetics
    • 3.3. Porter's Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Product
      • 3.4.2. Market attractiveness analysis By Route of Administration
      • 3.4.3. Market attractiveness analysis By Facility of Use
      • 3.4.4. Market attractiveness analysis by Region
  • Chapter 4. Global Topical Drug Delivery Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Topical Drug Delivery Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Facility of Use launches
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Topical Drug Delivery Market-Product Analysis
    • 5.1. Global Topical Drug Delivery Market overview: By Product
      • 5.1.1. Global Topical Drug Delivery Market share, By Product,2018 and 2025
    • 5.2. Semi-Solid Formulations
      • 5.2.1. Global Topical Drug Delivery Market by Semi-Solid Formulations, 2016-2025 (USD Billion)
    • 5.3. Transdermal Products
      • 5.3.1. Global Topical Drug Delivery Market by Transdermal Products, 2016-2025 (USD Billion)
    • 5.4. Solid Formulations
      • 5.4.1. Global Topical Drug Delivery Market by Solid Formulations, 2016-2025 (USD Billion)
    • 5.5. Liquid Formulations
      • 5.5.1. Global Topical Drug Delivery Market by Liquid Formulations, 2016-2025 (USD Billion)
  • Chapter 6. Global Topical Drug Delivery Market- Route of Administration Analysis
    • 6.1. Global Topical Drug Delivery Market overview: By Route of Administration
      • 6.1.1. Global Topical Drug Delivery Market share, By Route of Administration , 2018 and 2025
    • 6.2. Dermal Drug Delivery
      • 6.2.1. Global Topical Drug Delivery Market By Dermal Drug Delivery, 2016-2025 (USD Billion)
    • 6.3. Nasal Drug Delivery
      • 6.3.1. Global Topical Drug Delivery Market By Nasal Drug Delivery, 2016-2025 (USD Billion)
    • 6.4. Ophthalmic Drug Delivery
      • 6.4.1. Global Topical Drug Delivery Market By Ophthalmic Drug Delivery, 2016-2025 (USD Billion)
    • 6.5. Vaginal Drug Delivery
      • 6.5.1. Global Topical Drug Delivery Market By Vaginal Drug Delivery, 2016-2025 (USD Billion)
    • 6.6. Rectal Drug Delivery
      • 6.6.1. Global Topical Drug Delivery Market By Rectal Drug Delivery, 2016-2025 (USD Billion)
  • Chapter 7. Global Topical Drug Delivery Market- Facility of Use Analysis
    • 7.1. Global Topical Drug Delivery Market overview: By Facility of Use
      • 7.1.1. Global Topical Drug Delivery Market share, By Facility of Use , 2018 and 2025
    • 7.2. Homecare Settings
      • 7.2.1. Global Topical Drug Delivery Market By Homecare Settings, 2016-2025 (USD Billion)
    • 7.3. Burn Centers
      • 7.3.1. Global Topical Drug Delivery Market By Burn Centers, 2016-2025 (USD Billion)
    • 7.4. Hospitals & Clinics
      • 7.4.1. Global Topical Drug Delivery Market By Hospitals & Clinics, 2016-2025 (USD Billion)
    • 7.5. Other Facilities
      • 7.5.1. Global Topical Drug Delivery Market By Other Facilities, 2016-2025 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Nestle S.A.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Johnson & Johnson
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. GlaxoSmithKline plc
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Novartis AG
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Merck & Co
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Bausch Health Companies Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Hisamitsu Pharmaceutical Co., Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Bayer AG
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Cipla Limited
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Glenmark Pharmaceuticals
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Mylan N.V.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Crescita Therapeutics Inc.
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product Portfolio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development

Methodology

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com